MedPath

Investigating the effect of vitamin E on the Treatment of Neonatal Hyperbilirubinemia

Phase 3
Conditions
eonatal Hyperbilirubinemia.
Neonatal jaundice due to other excessive hemolysis
Registration Number
IRCT20220806055625N2
Lead Sponsor
Sanandaj University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

Term infants with hyperbilirubinemia admitted to the neonatal department of Besat Sanandaj Hospital in 1401
Gestational age from 37 weeks to 42 weeks and 6 days
Birth weight from 2500 Grams to 4000 Grams

Exclusion Criteria

Evidence of infection
Congenital malformation
History of phenobarbital use in mother
Hypothyroidism
Inappropriate intrauterine growth
Oral intolerance
Mechanical ventilation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean serum total bilirubin. Timepoint: Serum total bilirubin 24 hours, 48 hours and 72 hours after intervention in two groups. Method of measurement: Taking blood samples from the infants in the study at 24 hours, 48 hours and 72 hours after the intervention by a trained nurse and sending them to the lab.;Mean serum indirect bilirubin. Timepoint: Serum indirect bilirubin 24 hours, 48 hours and 72 hours after intervention in two groups. Method of measurement: Taking blood samples from the infants in the study at 24 hours, 48 hours and 72 hours after the intervention by a trained nurse and sending them to the lab.;The amount of changes in the mean serum total bilirubin. Timepoint: Before the intervention and 24, 48 and 72 hours after the intervention. Method of measurement: Comparing the average total serum bilirubin before the intervention and the average total serum bilirubin obtained 24, 48 and 72 hours after the intervention.
Secondary Outcome Measures
NameTimeMethod
The average number of hospitalization days of newborns in two groups. Timepoint: Number of hospitalization days 24 hours, 48 hours and 72 hours after intervention in two groups. Method of measurement: Registration the number of hospitalization days of the newborns according to the file by a trained nurse.;The average hours of receiving phototherapy for newborns in two groups. Timepoint: Number of hours receiving phototherapy 24 hours, 48 hours and 72 hours after intervention in two groups. Method of measurement: Registering data of number of hours receiving phototherapy by a trained nurse.;Possible complications of vitamin E drug. Timepoint: 24 hours, 48 hours and 72 hours after the intervention in two groups. Method of measurement: A booklet containing the desired questions related to possible complications (these complications are selected by reviewing the literature) is provided to the mothers of babies and is followed up by a trained nurse.
© Copyright 2025. All Rights Reserved by MedPath